AKT (among other cell survival pathways) is also activated by RTKs, which are often significantly overactivated in GBM through a combination of either gene amplification, ligand and receptor overexpression, or, mutations conferring constitutive activation such as EGFRvIII [22]. The gene discussed is AKT1; the disease is glioblastoma.